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Interaction in free solution of purified preparations  of the first four reacting 
components  of human  complement  (C'I  esterase,  C'4,  C'2,  and  C'3)  x in  the 
presence  of Mg  ~+ results  in generation  of a  biological  activity which satisfies 
criteria for designation as anaphylatoxin  (1).  The biological properties of such 
mixtures  include  contraction  of guinea  pig  ileum  with  tachyphylaxis,  failure 
to  contract  rat  uterus,  enhancement  of  vascular  permeability  in  guinea  pig 
skin,  degranulation  of mast  ceils  in  guinea  pig  mesentery  preparations,  and 
release of histamine from suspensions of rat peritoneal mast cells. These obser- 
vations  were  an  outgrowth  of earlier  studies  on  the  role of C'I esterase  as  a 
permeability factor (2),  and in  the generation of anaphylatoxin  activity from 
fresh guinea pig or rat  serum  (3,  4). 
The  possibility  that  anaphylatoxin  emerges  as  a  reaction  product  at,  or 
shortly  after,  completion  of  the  C'3  step  in  the  complement  sequence  was 
suggested by previous experiments based on such indirect criteria as a  require- 
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iThe complement system,  as presented  and discussed in this  paper,  comprises II serum 
proteins. C'I is a macromolecular complex of three proteins,  C'lq, C'lr, and C'Is. The enzy- 
matically active subunit derived from Cqs is referred to as C'I esterase. Subsequently acting 
components, in the order of their reaction, are C'4, C'2, C~3, C'5, C'6, C'7, C% and C'9. 
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ment  for  Mg  2+  and  inhibition by salicylaldoxime and phlorizin (4).  C'3  was 
further implicated as a  component from which anaphylatoxin might be derived 
by the findings that biologically active mixtures could be prepared from human 
C'1  esterase,  C'4,  C'2,  and  C'3  without  known  participation of later acting 
components;  that  the muscle-contracting activity of such mixtures was  asso- 
ciated with fractions of lower molecular weight than any of the reactants; and 
that  appearance  of  biological activity was  closely correlated with  immuno- 
electrophoretic  conversion  of  C'3  to  anodically  faster  components  (1,  5). 
Through the use of labeled, purified components of human complement and by 
separation of  the  active product by gel filtration or sucrose  density gradient 
ultracentrifugation,  we  have  now  shown  that  generation  of  anaphylatoxin 
from  mixtures  of  C'1  esterase,  C'4,  C'2,  and  Ct3  is  a  direct  consequence  of 
cleavage of C'3, yielding a  low molecular weight split product which possesses 
all of the biological properties of the original mixture. It is the purpose of this 
paper  to  present  evidence  supporting  this  conclusion  and  to  describe  some 
characteristics of the reaction mechanism  and of the isolated product. 
Materials and Methods 
Preparation,  Assay,  and  Labeling  of Human  Complement  Components 
Serum.--Blood was collected without anticoagulant from apparently healthy human donors 
and allowed to clot at room temperature for 1-2 hr and at 2°C for several additional hours or 
overnight. Serum was separated by centrifugation at 2°C. Pools of serum from 2-25 donors 
were either used immediately or stored at --60°C. 
C'1 Esterase, C'4, C'g, and C'3.--These components were prepared, assayed and stored by 
modifications  of published procedures (6-9),  exactly as described  in a  previous paper (1). 
C'5.--This component  was prepared as a by-product of C'3 purification,  as described by 
Nlisson  and Miiller-Eberhard (9).  Functional activity was measured  by restoration of the 
hemolytic activity of human serum treated with ~  potassium thiocyanate  (KSCN),  in the 
presence of purified C~3 and C'4 (10). Preparations of  C~5  were free from immunologically 
detectable C'3 and C'4. They were either used fresh or quick-frozen in dry ice-acetone and 
stored at --50°C. A single preparation of highly purified C'5 was also kindly donated by Dr. 
H. J. Mtiller-Eberhard and gave results comparable to those obtained with C'5 made in this 
laboratory. 
Labeling of Complement Components.--C'l esterase,  C'4, C'2, C'3, and C'5 were labeled 
with x26I or mI. The results were independent of the iostope used; only experiments with mI 
will be reported here. Labeling was performed in pI-I 8.0 borate buffer by the iodine  monochlo- 
ride method of Helmkamp and coworkers (11) at a tagging efficiency ranging from 40-80%. 
The extent of labeling did not exceed I atom of iodine per molecule of protein. Unbound iodine 
was removed by exhaustive dialysis against 0.15 xt NaC1 and then PBS buffer (pI-I 7.4 phos- 
phate-buffered  saline, 5 X  10  -4 ,J Mg  z+) at 2°C, followed by concentration of the labeled pro- 
tein by ultrafiltration and either passage through Biogel P-60 or ultracentrifugation in 5-20% 
sucrose density gradients. The final preparations, in PBS buffer, were either used directly or 
first diluted with unlabeled component to reduce the amount of radioactivity  introduced into 
reaction mixtures. Functional integrity of labeled components was determined both by hemo- 
lytic assays and, with the exception of C'5, by participation in the generation of biological 
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Immunological Reagents and Procedures 
Antisera.--Rabbit  and horse antisera to whole human serum were obtained commercially 
(Behringwerke, Marburg-Lahr,  West Germany). Antisera to human C'3, C'4, and C'5 were 
raised in rabbits by Dr. J. T. Boyer, using highly purified components prepared in this labora- 
tory. 
Immunoelectrophoresis.--Tmmunoelectrophoretic analyses  in 1%  agar were performed  by 
the micromethod of Scheidegger (12) at a potential gradient of 9 v per cm for 70 vain. 
Double Diffusion in Agar.--A microproeedure using glass microscope slides covered with a 
gel of 1% agar was employed. Wells were punched with a commerdal template (LKB-Produ- 
kter, Stockholm, Sweden). This technique, described by Crowle (13),  is more sensitive than 
immunoelectmphoresis and was used for immunological evaluation of purity of complement 
components. 
Chemicals and Chemical Methods 
Triethanolamine-Buffered Saline (TBS).--This buffer, at pH 7.4 and ionic strength 0.15, 
was used as diluent in all hemolytic assays.  For reactions preceding the C'3 step of immune 
hemolysis, it contained 1.5 X  10  -4 x~ Ca~+ and 5 X  10  -~ ~  Mga+; for subsequent reactions, it 
contained 8  X  10  -s M NaffIEDTA. 
Phosphate-Buffered Saline (PBS).--This buffer, at pH 7.4 and ionic strength 0.15, was used 
as diluent in all free solution experiments to be described. It was composed of 0.135 # sodium 
chloride, 0.015 # sodium phosphate, and 5  X  10-~ Mg  2+. 
Glydr~-Buffcted Saline (GBS).--This buffer, at pH 3.5 and ionic strength 0.15, was used, 
unless otherwise indicated, for equilibration and elution of gel filtration columns and as diluent 
in sucrose density gradient ultracentrifugation. It was composed of 0.149 # sodium chloride 
and 0.001 # giycine buffer at pH 3.5. 
Protein Det~rminations.--Protein concentrations of components of complement were either 
measured by the method of Lowry and coworkers (14) or estimated by absorption at 280 m#, 
assuming a value for Et om of 10. For estimation of minute amounts of protein or polypeptide 
in retarded fractions from gel filtration columns and  in  concentrated preparations  of such 
fractions, absorption at 210 m# was employed, assuming a value for E  ~m of 205. 
Gel lCiltration.--Polyacrilamide gels  (Bio-Gel  P-60,  50-100  mesh; Bio-Gel P-10,  50-150 
mesh) were obtained from Bio-Rad Laboratories, Richmond, Calif. Sephadex G-75 (40-120 #) 
was  obtained  from  Pharmacia,  Uppsala,  Sweden.  Glass columns of  1.5  cm diameter were 
packed under gravity flow in equilibration buffer to heights of 30 to 80 cm in various experi- 
meats, Elution was accomplished at 4°C at flow rates Of 5-30 ml per hr. Fractions of equal 
volumes were collected by means of a volumetric siphon or drop counter. The elution positions 
of substances with known molecular weights were determined in the same manner. For this 
purpose, Blue Dextran 2000 (Pharmacia) was used to define the V0 (void volume) of the col- 
umn. Cytochrome c (Nutritional Biochemicals Corp., Cleveland, Ohio), porcine zinc insulin 
and glucagon hydrochloride (Eli Lilly and Co., Indianapolis, Ind.) were selected as molecular 
weight markers of 12,400, 5800, and 3485, respectively. All of these were used at a concentra- 
tion of 1% and were dissolved in GBS. The elution profile of Blue Dextran was monitored by 
reading absorption of fractions at 600 m#; cytochrome c at 410 m#; and insulin and glucagon 
at 280 m#. The position of elution of nSI-anaphylatoxin was compared with these markers and 
its molecular weight estimated by the method of Andrews (15). 
Sucrose Density Gradient Ultracentrifugation.--The technique of Martin  and Ames (16), 
modified as described previously (17), was used to produce linear 5-20% sucrose gradients in a 
volume of 4.5 ml. Samples (0.2 ml) were layered on the gradients and centrifuged in a swinging 
bucket  rotor  (SW-39)  in the model L  Spineo ultracentrifuge  (Beckman Instruments,  Inc., 1030  COMPLEMENT AS  MEDIATOR OF  INFLAMMATION. III 
Spinco Div., Palo Alto, Calif.) at 35,000 rpm for 20 hr at a chamber temperature of 5-I0°C. 
Each lusteroid centrifuge tube was then emptied by piercing the bottom with a fine gauge 
needle and collecting 19-21 fractions of 18 drops each. 
For purposes of monitoring the efficiency of protein separation, the sample of one of three 
gradients used in each run consisted of 0.2 ml of a mixture of 1% human  ~,G-globulin (American 
Cyanamid Co., Lederle Laboratories Div., Pearl River, N. Y.) and 1% cytochrome c. The 
fractions obtained from this tube were diluted with 3.0 ml of 0.15 ~t NaCI and read at 210 and 
410 m#, respectively, to define the positions of molecular weight markers of 144,000 and 12,400. 
Measurement of Radioactivlty.--A scintillation well counter (Model 2804, Picker Nuclear 
Instruments, Cleveland, Ohio) was used to measure the radioactivity of mI-labeled compo- 
nents of complement and fractions obtained from reaction mixtures containing a labeled com- 
ponent. Samples were placed in 12 X  75 mm polystyrene tubes in uniform volumes, inserted 
into carrier tubes, and counted for 1.0 min. 
Concentration of Isolated Anaphylatoxin.--Biolo~cally active fractions retarded on gel filtra- 
tion columns were pooled and concentrated by ultrafiltration at 4°C at pressures of 30-40 psi 
of N2 in a Diaplex Ultrafil apparatus, Model 50 fitted with Diaflo UM-2 or UM-3 membranes 
(Amicon Corporation, Cambridge, Mass.). The concentrated material in GBS buffer (pH 3.5) 
was used at once or frozen at --60°C. Neutralization to pH 7.4, where necessary, was performed 
immediately before use. 
Proteolytic Enzymes.--The susceptibility of isolated anaphylatoxin to destruction by endo- 
and exopeptidases  was tested during incubation at 37°C at indicated concentrations and pH 
values. The enzymes employed were: trypsin (2 X  crystallized), a-chymotrypsin (3 X  crys- 
tallized), and carboxy-peptidase B, all obtained from Worthington Biochemical Corp.,  Free- 
hold, N. J. 
Biological  Materials and Procedures 
Histamine, Bradykinin, Triprolidine, Pontamine Sky Blue, and Rat Agar Anaphylatoxin.-- 
These materials were obtained and used exactly as described  in a previous paper (1). 
Contraction of Smooth Muscle Preparations, Enhancement of  Vascular Permeab41ity, De- 
granulation of Mast Cells in Guinea Pig Mesentery, and Release of Histamine from Isolated Rat 
Peritoneal Mast Cells.--These procedures were performed exactly as described in a previous 
paper (1) by modifications of published methods (4, 18-21). 
l~SWLTS 
Characterization  of the Smooth Muscle-Contracting Activity Generated from 
Mixtures of Purified Human C'I Esterase, C'4, C'2, and C'3 as a Cleavage 
Product of C'3 
Preliminary Experiments and General Experimental Design.--Initial attempts 
to isolate biologically active fractions from reaction mixtures of  C'I  esterase, 
C'4,  C'2, and C'3 by gel filtration or sucrose density gradient ultracentrifuga- 
tion were unsuccessful. In these  experiments,  in which fractionation was  per- 
formed  in  PBS  buffer  at  pH  7.4,  smooth  muscle-contracting  activity  could 
usually not be detected in any individual fraction or any combination of frac- 
tions. It was further observed that most of the activity in the original reaction 
mixture was no longer present after standing at 4°C for periods of time corre- 
spending  to  the  duration of  gel  filtration or  ultracentrifuge  runs.  Mter  con- 
siderable trial and error, it was found that smooth muscle-contracting activity, W.  DIAS  DA  SILVA,  J.  W.  EISELE~  AND  I.  H.  LEPOW  1031 
once generated, could be stabilized by acidification to pH values of 2-5, repre- 
senting an independent confirmation (5)  of a  previous report by Stegemann, 
Vogt, and Friedberg (22). This empiric observation, later confirmed by Miiller- 
Eberhard  and  coworkers  (23),  made  possible  the  following  experimental 
approach. 
Individual purified  components  of human  complement were  labeled with 
125I, were shown to retain functional activity, and were then employed in reac- 
tion mixtures with other unlabeled components. The labeled component was 
either used as is or diluted with the same unlabeled component with qualita- 
tively similar results. Reaction mixtures consisted of Ctl esterase (5 units per 
ml),  Ct4 (50 t~g per ml),  C'2 (50--75 ~g per ml), and C'3  (500  t~g per ml) in 
PBS buffer (pH 7.4 phosphate-buffered saline, 5 X  10  -4 ~r Mg~+). Three of the 
components of complement were preincubated at 37°C for 3 rain. The missing, 
prewarmed component (Ctl esterase) was added at zero time. Incubation was 
continued at 37°C for 10 min, an aliquot (0.05 mi) was removed and put into 
ice for immunoelectrophoresis (IEP),  and the remainder of the solution was 
then brought to pH 3.5 with 0.1 ~  HC1 and cooled in ice. The sample for IEP 
was not acidified because of loss of reactivity of Ct3 with antiserum at pH 3.5. 
A control mixture was always prepared of identical composition to the experi- 
mental, except that one component of complement was omitted and replaced 
by PBS buffer. In one experiment to be illustrated, 1~5I-Cr5 (26 ~g per ml) was 
included in the reaction mixture, all other conditions remaining the same. In 
this case,  the C~5 was used entirely in the form of labeled component. 
Experimental and control mixtures were assayed for contraction of guinea 
pig ileum and immunoelectrophoretic conversion of C"3. In all cases, the con- 
trol was inactive on ileum and Ct3 was unaltered in IEP; the complete mixture 
contracted guinea pig ileum with tachyphylaxis at a  test dose of 0.05 ml in a 
5 ml organ bath and showed complete conversion of C~3 to anodically faster 
components in IEP. The IEP patterns obtained are represented by Fig. 3 in 
reference (1)  and will not be repeated here. 
Acidified experimental and control mixtures (0.2  ml)  were then applied to 
5-20%  sucrose  density  gradients  in  GBS  buffer  (pH  3.5  glyclne-buffered 
saline). The experimental mixture was applied to a column (1.5 >(  70-80 cm) 
of Biogel P-60 in GBS buffer (2.8 ml of sample), the control being held over 
night at 4°C for application to the same P-60 column at the time of completion 
of the experimental run. Finally, a mixture of Blue Dextran and cytochrome 
c was placed on the same column as markers for the V0 of the column and the 
position of elution of a  protein of molecular weight 12,400. 
Gel filtration fractions (3.0  ml) were assayed for contraction of guinea pig 
ileum at a test dose of 0.5 ml and sucrose density gradient fractions (circa 0.2 
ml) at a dose of 0.1 ml. Because of tachyphylaxis and the variability of differ- 
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muscle-contracting activity of various fractions and results are recorded only 
as presence or absence of detectable activity. The region of biological activity 
of retarded fractions from P-60 columns was usually signaled by a small increase 
in absorption at 210 inv. Radioactivity was measured in aliquots (1.0 ml) of 
the gel filtration fractions and in the entire fraction from sucrose density gra- 
dients prior  to  testing on ileum. Results are  expressed graphically, plotting 
the position of fractions from P-60 columns and sucrose density gradients vs. 
radioactivity and biological  activity. Positions of markers are  also included. 
For purposes of graphic presentation, the relatively small amount of labeled 
fragment obtained in some experiments has been magnified by uniform use of 
a logarithmic scale for plotting radioactivity (ordinate). 
Experiments with 125I-C'3.--A typical experiment with ~5I-C'3 and unlabeled 
C'I  esterase,  C'4,  and  Ct2  in sucrose  density gradient ultracentrifugation is 
shown in Fig. 1 (left). It is apparent that this reaction mixture, which contained 
biological activity, yielded a low molecular weight, labeled product associated 
with smooth muscle--contracting activity. A control mixture of identical com- 
position except for absence of C'I esterase was biologically inactive and failed 
to yield a  low molecular weight, labeled product.  This  result,  coupled with 
immunoelectrophoretic conversion of C'3 only in the complete reaction mixture, 
was highly suggestive of a  mechanism involving cleavage of  C'3  to  yield a 
biologically active fragment. 
Comparable  data were obtained when the same mixtures were  applied  to 
columns of Biogel P-60  (Fig.  1,  right).  Retarded fractions forming a  radio- 
activity peak  associated with ileum-contracting activity were obtained from 
the reaction mixture of all four components. This finding was somewhat com- 
promised by the presence of a very highly retarded radioactivity peak in the 
control mixture, the exact nature of which is unknown. However, this peak was 
present in both  the  complete  and  control mixtures  and  was  not related  to 
biological activity, while the  earlier peak  associated with ileum contraction 
was seen only in the complete mixture. The conclusion appeared reasonable, 
therefore, that fractions eluting at 83-126 ml from Biogel P-60  corresponded 
to fractions sedimenting at 3.9-4.3 ml in sucrose gradients. 
The amount of radioactivity present in low molecular weight fractions ob- 
tained by these two techniques was about 5 % of the total radioactivity recov- 
ered.  The  active  fragment behaved  as  a  molecule  of  lower  sedimentation 
velocity and smaller hydrodynamic volume than cytochrome c. The sedimen- 
tation velocity of C'3 was not detectably altered, further indicating the small 
size of the active fragment, and also providing evidence for a discrete cleavage 
into  large  and  small pieces  of  the  C'3  molecule,  rather  than  into  multiple 
fragments. The significance of the difference in amount of very rapidly sedi- 
menting material in the complete and control mixtures in Fig. 1 (left)  is not 
known. i' 
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Experiments with 125I-Ctl Esterase, I*nI-C'4, and 12sI-C'2.--The data presented 
in  the previous section strongly indicated  that  generation  of smooth muscle- 
contracting activity in mixtures of C'I esterase, C'4, C'2, and C'3 was a conse- 
quence  of  cleavage of  C'3.  However, before  this  conclusion  could be drawn 
with greater  certainty,  it was necessary to perform similar  experiments  with 
other labeled components. In each case, ileum-contracting  activity was always 
found  in  low molecular  weight fractions  obtained from sucrose  gradients  or 
columns of Biogel P-60, but these fractions were not associated with a  radio- 
activity peak.  Thus,  only when  C'3  was labeled  did  increased  radioactivity 
appear in the fractions having biological activity. Several interesting ancillary 
observations also emerged from this series of experiments. 
When  1~5I-C'1 esterase  was  employed  with  unlabeled  C'4,  C'2,  and  C~3, 
(C'2 being omitted in the control mixture), it was dear that ileum-contracting 
activity was not associated with a radioactivity peak in either sucrose density 
gradient ultracentrifugation  or gel filtration  (Fig. 2). Of separate interest was 
the distribution of radioactivity of C'I esterase into lighter and heavier peaks 
in  sucrose  density gradient  ultracentrifugation  (Fig.  2,  left).  Since  a  highly 
purified preparation of C'I esterase had been labeled, it was expected that only 
the lighter peak (circa 4S) would be found. Indeed, when the same preparation 
of 125I-C'1 esterase was subjected to sucrose density gradient ultracentrifugation 
at pH 3.5 in the absence of other  components,  a  single radioactivity peak in 
the  4S  position  was  obtained.  The  heavier  peak,  therefore,  most  probably 
represented  a  complex between  C'I  esterase  and  another  constituent  of  the 
reaction  mixture.  Since  the  same  dual  peaks  were  observed  in  the  control 
lacking  C'2  (Fig.  2,  left),  this  component  could  be  ruled  out.  The  relative 
importance of C'4 and  C'3 in this phenomenon has not yet been determined, 
although  the  propensity of C'4  to  complex with  other  proteins  has  been de- 
scribed (24). 
When  1~5I-C'4 was  employed  with  unlabeled  C'I  esterase,  C'2,  and  C'3, 
(C'I esterase being omitted in the control mixture),  ileum-contracting  activity 
was not associated with a  radioactivity peak in separations  performed by gel 
filtration  (Fig.  3,  right).  The  distribution  of radioactivity  of  C'4  in  sucrose 
density gradient  ultracentrifugation  (Fig.  3,  left)  indicated  the presence of a 
low molecular weight fragment of Cr4 in the complete mixture of four compo- 
nents.  Ileum-contracting  activity was found along  the  descending  portion  of 
this radioactivity peak, rather than with the peak itself. A fragment of Cr4 had 
been unsuccessfully sought in previous experiments on the effect of C'I  esterase 
on C'4, in which a slight reduction in sedimentation velocity of the main peak 
of C'4 seen in Fig. 3 (left) was also observed (24). The possibility that the slowly 
sedimenting peak of radioactivity in Fig. 3 is indeed a fragment of C'4 which 
is visualized at pH 3.5 but not at pH 7 (24), requires further exploration. 
When 125I-C'2 was employed with unlabeled C'I esterase, C'4, and C'3,  (Ct4 W.  DIAS  DA  SILVA~  J.  W,  ~ISELE~  AND  I,  ft.  LEPOW 
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being omitted in the control mixture), it was again apparent that ileum-con- 
tracting activity was not associated with a radioactivity peak (Fig. 4). In this 
case, the distribution of radioactivity of CP2 in sucrose density gradient ultra- 
centrifugation was essentially the same in the complete mixture and the control. 
In summary, labeling of Cq esterase,  Cr4, or C~2 indicated that none of these 
components served as a direct source of the biologically active fragment gener- 
ated from mixtures  of Cq  esterase,  C~4, C~2, and  C~3. Although all four of 
these components were required in the reaction mixture,  the active fragment 
appeared to be derived only from CP3. 
Experiments with ~sI-C~5.--It  was previously reported that addition of C"5 
(11-113 ~g per ml)  to mixtures of C'I esterase,  C~4, C~2, and C~3 neither aug- 
mented nor inhibited the generation of smooth muscle contracting activity (1). 
The possibility nevertheless existed that cleavage of C15 might have occurred 
without  affecting  measurable  biological  activity.  Accordingly,  experiments 
were performed with 1~5I-Ct5 and unlabeled Cq  esterase,  C"4, C12, and  C~3. 
A control lacking Cq esterase but containing the other four components was 
also prepared. The results (Fig. 5) failed to provide any evidence of C'5 cleavage 
under the conditions of the experiment. Not shown are an additional control 
lacking  CP3 but containing  Cq  esterase,  C~4, CP2, and mI-C~5, and another 
reaction mixture  of five  components containing  30 #g per ml  of a  different 
batch of "sI-C"5.  These yielded results entirely comparable to those shown in 
Fig.  5.  These  experiments,  therefore,  provided  further  confirmation  of  the 
conclusion  that  the  smooth  muscle-contracting  activity generated  in  these 
systems resided in a  cleavage  product of C~3. 
Experiments  with ~sI-C~3 at pH 7.4.--In  all  of the experiments described 
above, the reaction was performed at pH 7.4 but the mixture was then brought 
to pH 3.5 and separations carried out at pH 3.5. When mixtures of C'I esterase, 
C'4,  C~2, and nsI-CP3 were prepared at pH 7.4, and sucrose density gradient 
ultracentrifugation  and  gel  filtration  performed  at  pH  7.4, low  molecular 
weight fractions with detectable ileum-contracting activity were not obtained, 
despite the presence of activity in the freshly prepared mixtures. Furthermore, 
the well-defined radioactivity peaks near the top of gradients or in a retarded 
position in gel filtration, as in Fig. 1 at pH 3.5, were replaced by shallow eleva- 
tions of radioactivity only slightly greater than baseline levels. These findings 
were  in  accordance  with  preliminary  failures  to  isolate  biologically  active 
fractions from reaction mixtures at pH 7.4, and provided additional evidence 
for the identity of the labeled fragment in Fig. 1 with the activity responsible 
for ileum  contraction.  The  observations also lend support  to  the possibility 
that the fragment undergoes an aggregration  or association reaction at pH 7.4 
which is prevented or reversed at low pH,  as proposed by Miiller-Eberhard 
and coworkers (23). 1038  COMPLEMENT  AS  EEDIATOR  OF  INFLAMMATION.  II[ 
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Additional  Parameters Affecting  the Generation of Smooth Muscle--Contracting 
A ctivity from Mixtures of Purified C'1 Esterase, 
C'4, C'2, and C'3 
It was shown previously that generation of biological activity from mixtures 
of C'I esterase, C'4, C'2, and C'3 occurred very rapidly at 37°C within phys- 
iological concentrations of these reactants, required Mg  2+, and was associated 
with immunoelectrophoretic conversion of C'3 (1). A few additional parameters 
have now been studied from the standpoint of the probability of an enzymatic 
mediation of C'3 cleavage. The concentrations of components employed in this 
series of experiments were 5  units per ml of Cq esterase, 50 ug per ml of C'4, 
50 tzg per ml of C'2, and 500 ug per ml of C'3. 
Effect  of pBr.--Cq  esterase,  C'4,  C'2,  and  C'3  were  dialyzed against 0.15 
NaC1  containing 5  X  10  -~ M Mg  ~+. Michaelis universal buffers (acetate- 
barbiturate) at 0.15  # were prepared over a wide range of pH. Reaction mix- 
TABLE I 
Effect of pH on Generation of Smooth Musde-Con~ractlng Activity in Mixtures of C'1 Esterase, 
Ct  4, C'Z,  and C'3 
m~pH  ......  3.5  5.0  6.0  7.0  7.4  %9  8.5  8.8 
.'ontraction  of guinea pig ileum, mm  0  0  8  90  80  76  62  12 
tures were constructed in such a  way that 37% of the total volumes consisted 
of Michaelis buffers.  Final pH  values,  after incubation at 37°C  for  5  rain, 
varied in increments between 3.5  and 8.8.  Activity on guinea pig ileum was 
assayed at a  test dose of 0.05  ml (pH 3.5 and 5.0)  or 0.02  ml (all other pH 
values).  The  results  (Table  I)  demonstrated  an  optimum  in  the  region  of 
physiological pH  for generation of ileum-contracting activity,  with marked 
inhibition at pH 6.0 and 8.8.  More precise definition of the pH optimum was 
precluded by the variability of the guinea pig ileum assay. 
Effect of Preincubating Mixtures of C'1 Esterase and C'4 Prior to Addition of 
C2 and C'3.--C'1  esterase and C'4 were incubated together in PBS buffer at 
37°C for periods between 0 and 60 min, at which time the mixtures were com- 
pleted by addition of C'2 and C'3 in PBS buffer. After further incubation at 
37°C for 5 rain, the samples were cooled in ice and assayed on guinea pig ileum 
at a test dose of 0.05 ml. No difference in activity of any of these samples was 
detectable.  All  elicited a  full contraction on first  application  and  a  partial 
contraction on second application to ileum. Thus, interaction of Cq  esterase 
and C'4 did not yield a product subject to decay as a function of time. 
Effect of Preincubaling Mixtures of C'I Esterase, C4, and C'2 Prior to Addition 
o/C'3.--Cq  esterase, C'4, and C'2 were incubated together in PBS buffer at 
37°C for 0, 2, 5, 10, 20, 30, and 45 min, at which time the mixtures were corn- W.  DIAS  DA  SILVA,  J'.  W.  EISELE,  AND  I.  H.  LEPOW  1041 
pleted by addition of C'3 in PBS buffer. Mter further incubation at 37°C for 
5 rain,  the samples were cooled in ice, assayed on guinea pig ileum at a  test 
dose  of 0.05  ml,  and  analyzed for immunoelectrophoretic (IEP)  conversion 
of C'3.  The results  (Table II)  indicated  rapid  decay of the mixture of  Cq 
esterase,  C'4,  and  Ct2,  and a  satisfactory correlation between generation of 
ileum-contracting activity and IEP conversion of Ct3. In separate experiments, 
it was shown that the decay was not attributable to instability of any of the 
reactants individually. Indeed, preincubation of mixtures of CP4, C'2, and Ct3 
at 37°C for periods of time up to 60 rain did not adversely affect generation 
of ileum-contracting activity upon addition of C'I esterase. Since it had already 
TABLE II 
Effect of Preincubation of C'I  Esterase, Ct4, and  Ct2 
Preincubation at 37°C for various periods of time prior to addition of C~3 on generation 
of smooth-muscle  contracting activity. 
Time at 37"C  Contraction of guinea pig ileum*  IEP conversion of C'35 
rain 
o 
2 
5 
10 
20 
30 
45 
4+ 
4+ 
2+ 
-4- 
0 
0 
0 
4+ 
4+ 
4+ 
2+ 
0 
0 
0 
* Expressed on a scale of 0 to 4+, where 4+ represents a full contraction. 
Expressed on a scale of 0 to 4+, where 4+ represents complete IEP conversion  of Ct3 
to anodically faster components. 
been shown that mixtures of C'I esterase and C'4 were not subject to decay, 
it was concluded that further interaction with C'2 yielded a labile reactant. 
All  available  data  on  the  biochemical  characteristics  of  the  interaction 
of Cq esterase, Ct4, C~2, and C'3, leading to generation of biological activity, 
are fully consistent with an enzymatic mechanism in which  the penultimate 
step is activation of C•2  and the final event is cleavage of C'3. Although our 
experiments were not directed to this point, they are consistent with the report 
of Miiller-Eberhard  and  coworkers  (23)  that  the  action  of  C'I  esterase  on 
C'4 and C'2 leads  to formation of an enzyme, C'4-C'2a  ("C'3  convertase"), 
which then acts on Ct3. 
General Properites of the Isolated Fragment of C'3-F(a)C"3 
Nomenclature.--It  will be shown in a later section that the fragment of C~3 
with  ileum-contracting activity,' demonstrated in Fig.  1,  possesses all  of  the 1042  COMPLEMENT  AS MEDIATOR OF INFLAMMATION. III 
biological properties previously described for mixtures  of  C'I  esterase,  C'4, 
C'2,  and  C'3  (1). The isolated fragment, according to existing criteria, may 
therefore  be  designated  as  anaphylatoxin.  However,  it  has  been  found  in 
separate studies that a fragment of C'5 may also be obtained which has similar 
as well as unique biological properties and which also qualifies for designation 
as  anaphylatoxin  ~ (25).  Accordingly,  the  term  anaphylatoxin is  biologically 
descriptive of more than one chemical substance of different substrate origins 
and  a  more definitive nomenclature is  now  required.  In  an  informally con- 
stituted  group  of  active  investigators  in  complement  research,  it  has  been 
agreed  to  pattern  the  designation  of  fragments  and  polypeptide  chains  of 
complement components, as  they are obtained,  after the system adopted for 
immunoglobulins.  The cleavage product described in  this  paper is  therefore 
designated F(a)C'3, indicating that it is a fragment, F, of a  complement com- 
ponent, C'3. Use of the symbol (a)  is arbitrary and may be interpreted either 
as the first fragment found or as an abbreviation of anaphylatoxin. The letter 
is enclosed in parentheses in an attempt to avoid possible confusion with other 
usage of the letter a for an activated state of a  complement component. The 
remaining  large  fragment  of  the  C'3  molecule  would  then  be  indicated  as 
F(b) C'3. The cleavage reaction mediated by prior acting components of com- 
plement may therefore by written: 
C'4 -- C'2a 
C'3  > F(a)C'3 +  F(b)C'3 
Preparative Isolation  and  Concentration of F(a)C'3.--For  preparative  pur- 
poses, reaction mixtures of C'1 esterase, C'4, C'2, and C'3 in PBS buffer were 
constructed in 5-8 ml volumes, incubated at 37°C for 10 min,  and acidified 
to pH 3.5.  Concentrations of reactants were either maintained as in previous 
experiments or proportionately increased up to 50 % to generate larger amounts 
of F(a)C'3. The mixture was shown to be active on guinea pig ileum and an 
unacidified  sample  was  analyzed  immunoelectrophoretically  for  complete 
conversion of C'3. The acidified mixture was  applied to a  column (1.5  X  80 
cm) of G-75 Sephadex equilibrated with GBS buffer (pH 3.5) and eluted with 
GBS buffer in 3.0 ml fractions at a flow rate of about 20 ml per hr. G-75 Sepha- 
dex has been found to give somewhat sharper resolution and better recoveries 
than  Biogel P-60.  The  emergence of retarded fractions was  indicated  by a 
shallow peak of absorption at 210 m~, maximal values reaching an OD of about 
0.25.  The limits  of the  zone of biological activity were defined by assay on 
guinea pig ileum at  a  test dose of 0.5  ml.  These corresponded to  the  more 
central portion of the OD  peak. Active fractions were pooled (about 30 ml) 
2  Dias da Silva, W., J. W. Eisele, and I. H. Lepow.  Complement  as a mediator of inflamma- 
tion. IV. Isolation and biological  properties of trypsin-split products of human C'3 and C'5. 
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and  concentrated  to  about  5  ml in  Diaplex  Ultrafil apparatus  with Diaflo 
UM-2 or UM-3 membranes. The final concentration of F(a)C'3 was estimated 
at about 30 ~g per ml by absorption at 210 m~. 
Stability  of F(a)C'3.--Concentrated  preparations  of  F(a)C'3,  maintained 
in GBS buffer, retained activity on guinea pig ileum for at least 24 hr at 4°C 
or  1 month at  --70°C.  Samples to be stored at low temperature were shell- 
frozen rapidly in  dry ice-acetone.  No  detectable  loss  of activity on guinea 
pig ileum occurred when F(a)C'3 was heated at 80°C for 30 min in GBS buffer; 
partial inactivation occurred at 100°C for 30 rain. Significant inactivation was 
observed after heating at 80°C for 30 rain at pH 7.2 but detectable activity was 
still present. It was apparent that isolated F(a)Ct3 was quite stable  to spon- 
taneous or thermal inactivation under these conditions. 
Estimated Molecular Weight of F(a)C3.--Employing  cytochrome c, insulin 
monomer,  and glucagon as molecular weight markers  on columns of Biogel 
P-10 in GBS buffer (pH 3.5),  attempts were made to estimate the molecular 
weight of F(a)Cr3 by the method of Andrews (15).  For this purpose, reaction 
mixtures of Cq  esterase,  C'4,  C~2, and ~5I-C~3 were applied to a  calibrated 
column of P-10 and the volume of emergence (V~) of the peak of the retarded 
radioactivity zone was determined. The position of this point on a  standard 
curve, relating the values of V~ for the markers as a function of the logarithm 
of their molecular weights, was used to estimate the molecular weight of labeled 
F(a)C'3.  It was recognized that the results obtained would be influenced by 
additional parameters,  such  as  asymmetry and hydration. In practice,  het- 
erogeneous radioactivity peaks were obtained with variably discrete resolution 
into  several  species  of  decreasing  molecular  weight.  The  highest molecular 
weight observed was 6800. Although the suggestion was present that the lower 
molecular weight species  might represent various dissociation products of the 
heaviest component, data now available do not permit this interpretation as 
a firm conclusion. 
Susceptibility of F(a)C'3 to Destruction by Endo- and Exopeptidases.--Aliquots 
of a  concentrated preparation of F(a)C'3 were incubated at 37°C for 10 rain 
with 3.3/~g per rnl of trypsin, a-chymotrypsin, or carboxypeptidase B  at pH 
7.4  in PBS buffer. The samples were cooled in ice and tested on guinea pig 
ileum. Treatment with each of these enzymes under these conditions resulted 
in complete loss of biological activity. These results were taken as supporting 
evidence that F(a)C'3 was, at least in part, polypeptide in nature. 
Biological Properties of F(a)Cr3 
Concentrated preparations  of  isolated F(a)C'3  were  tested  by previously 
described procedures for various biological properties known to be present in 
the original mixture of Cq esterase, Ct4, C~2, and C~3 from which the fragment 
was generated (1).  The results, summarized in Table III, demonstrated that 1044  COMPLEMENT AS  MEDIATOR OF INI~L/~ATION. III 
all  of  the  biological properties  of  the  original  mixture  were  associated  with 
F(a)C'3. Higher molecular weight fractions eluting with the V0 of Biogel P-60 
or  Sephadex  G-75  columns  were  biologically inactive.  It was  therefore  con- 
cluded  that  the  low  molecular  weight  cleavage  product  of  C~3, designated 
F(a) C'3, was itself the anaphylatoxin activity generated by interaction of the 
first four components of human complement in free solution. 
TABLE HI 
Summary of Biological Properties of Isolated F(a)CI  3 
Biological property*  Effect of F(a)C'3:~ 
Contraction of guinea pig ileum 
Cross-densensitization of guinea pig 
ileum with rat agar anaphylatoxin 
Contraction of rat uterus 
Enhancement  of  vascular  perme- 
ability in guinea pig skin 
Degranulation of mast cells in guinea 
pig mesentery preparations 
Histamine release from suspensions 
of rat peritoneal mast ceils 
Highly active (0.01 ml): tachyphylaxis; inhibited by 
triprolidine 
No cross-desensitization: contracted ileum previously 
desensitized with rat agar anaphylatoxin and vice 
versa 
Inactive (0.1 ml) 
Moderately active (0.1 ml): 4.3 mm of blueing, com- 
pared with 1.0 mm for buffer control, and 8.3 mm 
for 0.5 #g histamine; inhibited by triproildine 
Active (0.9 ml): 55% reduction of metachromaticaily 
staining mast ceils with morphological alterations 
of some residual ceils 
Active: linear dose-response curve; 30% release with 
0.8 ml 
* For methodology, see reference (1). 
:~ Preparations of isolated, concentrated F(a)CZ3 were estimated to contain about 30 #g 
per ml. 
DISCUSSION 
Experiments presented in this paper have demonstrated that the action of 
C~I esterase on C~4 and C'2 in the presence of Mg  2+ produces an activity capable 
of cleaving C~3 into large and small fragments. Essentially the same conclusions 
have been reached by MtiUer-Eberhard and coworkers (23)  and Cochrane and 
MiiUer-Eberhard (26), in turn based in part on studies in this laboratory (1, 5). 
The small fragment, now designated F(a)C'3  in a  nomenclature system con- 
sistent  with  that  employed for  immunoglobulin  degradation  products,  was 
shown  to possess all of the  biological properties previously found  in  unfrac- 
tionated reaction mixtures of CI1 esterase, C'4, CI2, and C'3 (1). F(a)C'3 could 
therefore  be  identified  as  the  anaphylatoxin  generated  in  this  free  solution 
system of purified components of human complement. The isolated fragment 
had an estimated molecular weight of 6800  or less by gel filtration techniques 
at pH 3.5,  was thermostable, and was susceptible to inactivation by trypsin, W.  DIAS  DA  SILVA,  ].  W.  EISELE,  AND  I.  H.  LEPOW  1045 
a-chymotrypsin, and  carboxypeptidase  B.  F(a)C'3  therefore  behaved  as  a 
large polypeptide or small protein fragment. The larger product of the reaction 
apparently represented  the remainder of the C'3 molecule and was designated 
F(b)C'3.  Isolation  of  pure  F(b)C'3  from  reaction  mixtures  is  in  progress, 
preparatory to amino acid and end-group  analyses  of C'3 and each of these 
products. 
Although it is now established  that F(a)C'3 is an anaphylatoxin generated 
by the action of prior reacting components of complement on C'3, the question 
remains of the inability to detect this property in fresh human serum incubated 
with Cil esterase or agar (4). Since we have found in unpublished experiments 
that both of these  agents cause immunoelectrophoretic  (IEP)  conversion of 
C'3,  the hypothesis is  reasonable  that F(a)C'3  may be  generated in  whole 
serum but that one or more mechanisms may exist by which it is rapidly bound 
or inactivated. Indeed, it has been our experience that mixtures of crude frac- 
tions of complement components  cannot be employed for generation of ana- 
phylatoxin, despite IEP conversion of C'3. This again suggests the existence of 
mechanisms  for blocking  the  activity of a  fragment which  may well have 
been formed. Investigations on the existence and nature of such mechanisms 
have not yet been systematically  performed. 
The ability of F(a)C'3 to liberate histamine from rat peritoneal  mast cells 
stands in contradistinction to the lack of activity in this system of classical 
anaphylatoxin, generated from fresh rat serum by agar (27). It is also note- 
worthy that F(a)C'3 contracted guinea pig ileum previously desensitized  by 
repetitive additions of rat agar anaphylatoxin, and vice versa. Thus, although 
F(a)C'3 shares many of the biological properties  of classical anaphylatoxin, it 
also behaves in part in a unique fashion. In recent experiments we have found 
that the unique properties  of human F(a)C'3 are not attributable to inherent 
differences between rat and human anaphylatoxins but rather to the existence 
of another fragment of different substrate origin  s (25). Treatment of human 
C'5 with 2/~g per ml of trypsin at 37°C for 5 rain liberates  a fragment which 
contracts guinea pig ileum with tachyphylaxis,  a fails  to contract rat  uterus, 
enhances  vascular permeability in  guinea pig  skin,  and  degranulates mast 
cells in guinea pig mesentery preparations.  However,  this fragment fails  to 
release histamine from rat peritoneal mast cells and does not contract guinea 
pig ileum previously desensitized  with rat agar anaphylatoxin. Conversely, if 
ileum is desensitized with the C'5 fragment, it will not respond  to a dilution 
of rat  agar anaphylatoxin but will contract upon addition of F(a)C'3. The 
trypsin-split product of C'5 further differs from F(a)C'3 in molecular weight, 
a value closer to that of cytochrome c being obtained by gel filtration at pH 
a Contractio  n of guinea  pig ileum  with tachyphylaxis  by mixtures  of human C'5 and trypsin 
was observed first by Drs. C. G. Cochrane  and H. J. Mtiller-Eberhard  in unpublished experi- 
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3.5. It would appear, therefore,  that this fragment of C'5 corresponds to clas- 
sical anaphylatoxin and to the activity generated by Jensen (28) from guinea 
pig  C'3b(C'5).  On  the  basis  of  cross-desensitization  of guinea  pig  ileum,  it 
would also be predicted to correspond to the anaphylatoxin formed by incuba- 
tion of fresh guinea pig or rat serum with C'1  esterase  (4).  In these terms, 
F(a)C~3  is  a  "new"  anaphylatoxin,  the  possible existence  of which  is  only 
sparsely  and  indirectly  intimated  in  the  literature  (29).  Anaphylatoxin  is, 
accordingly,  a term descriptive of a general range of biological Properties which 
are  in  part  shared  by distinctly  different  protein  fragments  derived  from 
different components of complement. The possibility is also admissable at the 
present  time  that  a  fragment  with  similar  properties  may be  obtained  by 
mechanisms  completely independent  of  a  component  of  complement  (30). 
Although  these considerations introduce further  complexities  into an already 
complex  area,  they also provide a  basis of understanding  of apparently con- 
tticting  data  (1,  28)  and  a  further  impetus  for investigations  on the  role  of 
complement in the pathogenesis of the acute inflammatory response. 
SUMMkRY 
Purified preparations  of human  C'1  esterase,  C'4,  C~2, CI3, and  C'5  were 
labeled with 1~5I. Reaction mixtures were prepared containing a single labeled 
component and other unlabled components. After incubation at 37°C  for  10 
min at pH 7.4 in the presence  of 5 X  10  -4 ~  Mg  2+, they were adjusted to pH 
3.5  and  subjected  to  sucrose  density  gradient  ultracentrifugation  and  gel 
filtration at pH 3.5. In all cases, an activity capable of contracting guinea pig 
ileum  with  tachyphylaxis  was  obtained  in  low molecular  weight  fractions. 
However, these fractions  were labeled only when ~5I-CI3 was employed, in- 
dicating  that  biological  activity was  associated with  a  cleavage product  of 
C~3. This fragment has been designated F(a)C~3 in a nomenclature consistent 
with that of immunoglobulin  degradation products. The much larger,  residual 
portion of the C'3 molecule has been designated F(b)C~3. 
The  biochemical  characteristics  of generation  of F(a)C~3  were  consistent 
with a mechanism involving action of C~1 esterase on CI4 and C'2, activation 
of C~2, and cleavage of C~3. 
F(a)C~3 had a molecular weight by gel filtration techniques of 6800 or less. 
It was thermostable and susceptible to inactivation by endo- and exopeptidases. 
The isolated fragment possessed all of the biological properties of unfractionated 
mixtures  of  Ctl  esterase,  C'4,  C'2,  and  Ct3.  In  addition  to  contraction  of 
guinea pig ileum,  these included failure  to contract rat uterus,  enhancement 
of vascular permeability  in  guinea  pig  skin,  degranulation  of mast  cells  in 
guinea pig mesentery, and release of histamine from rat peritoneal mast cells. 
F(a)C'3 did not cross-desensitize  guinea pig ileum  to  rat  agar  anaphylatoxin 
and vice versa. W.  DIAS DA SILVA~ J.  W.  EISELE~ AND I. H.  LEPOW  1047 
The existence of different protein fragments with anaphylatoxin properties 
has been discussed.  Distinctive  characteristics of F(a)C'3 from classical ana- 
phylatoxin generated by treatment of fresh rat serum  with  agar  have  been 
indicated. 
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